ロード中...
Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib
Ibrutinib is not known to confer risk for Pneumocystis jirovecii pneumonia (PCP). We observed 5 cases of PCP in 96 patients receiving single-agent ibrutinib, including 4 previously untreated. Clinical presentations included asymptomatic pulmonary infiltrates, chronic cough, and shortness of breath....
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064717/ https://ncbi.nlm.nih.gov/pubmed/27503501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-06-722991 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|